Clinical Trials Sponsored by Yellen & Associates, Inc

Total 257 results

CPL Associates
Astellas Pharma US, Inc.

Completed

Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections

Fungal Infection by Site

United States
Retina Associates, Kansas City
Genentech, Inc.

Unknown

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Proliferative Diabetic Retinopathy

United States
Entellus Medical, Inc.
North American Science Associates Inc.

Active, not recruiting

ClariFix Rhinitis RCT (CR RCT)

Chronic Rhinitis

United States
Relievant Medsystems, Inc.
M Squared Associates,Inc.; ProPharma Group

Completed

CLBP Single-Arm Long-Term Follow-up Study

Chronic Low Back Pain

United States
OrthoCarolina Research Institute, Inc.
Towson Orthopaedic Associates

Enrolling by invitation

Adductor Canal Block

Osteoarthritis | Total Knee Replacement

United States
Steve Yoelin M.D. Medical Associates, Inc.
Allergan

Completed

Evaluation of Skin Quality Improvement

Skin Quality

United States
San Bernardino Urological Associates Medical Group...

Completed

A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer

Cancer of Prostate

United States
Arshad Khanani
Genentech, Inc.

Completed

Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration

Neovascular Age-Related Macular Degeneration

United States
Southern New England Retina Associates
Genentech, Inc.

Completed

Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

Retinal Ischemia

United States
Barrie Urology Associates
Astellas Pharma Canada, Inc.

Completed

Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence

Urinary Bladder, Overactive

Canada
22nd Century Group, Inc.
Vince & Associates Clinical Research, Inc.

Completed

Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes

Tobacco Use

United States
Elpen Pharmaceutical Co. Inc.

Recruiting

Ezetimibe-Rosuvastatin Evaluation Study (ZEUS)

Hypercholesterolemia | Hyperlipidemias | Combinations of Drugs; Dependence

Greece
Elpen Pharmaceutical Co. Inc.

Completed

A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination (RETRIEVE)

COPD | COPD Exacerbation

Greece
Elpen Pharmaceutical Co. Inc.

Completed

AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice. (NOTOS)

Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II) (PROSPERITY)

Benign Prostatic Hyperplasia

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler

Asthma
Elpen Pharmaceutical Co. Inc.

Completed

Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice. (BOREAS)

Quality of Life | Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure (THETIS)

Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV
Elpen Pharmaceutical Co. Inc.

Withdrawn

Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation

Atrial Fibrillation

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Prospective Study of the Evaluation of Disease contRol and the Quality of Life of Patients With depressiOn and With or Without aNxiety disOrders in the Greek populatIon (PRONOI)

Depression | Anxiety Disorders

Greece
Elpen Pharmaceutical Co. Inc.

Completed

10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection

Helicobacter Pylori Infection

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice (SKIRON)

Quality of Life | Asthma | Satisfaction

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

Hypertension | Diabetes Mellitus | Renal Insufficiency | Sleep Apnea | Cardiac Arrhythmias

Greece
Elpen Pharmaceutical Co. Inc.

Completed

LevetIracetam in Patients Being Treated for Epilepsy (LIBERTY)

Epilepsy

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Antiplatelet Therapy Following Stent Implantation (Anti-Clot)

Angina, Unstable | Acute Myocardial Infarction | Coronary Syndrome

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Atorvastatin Study in Cardiovascular Disease Risk (ANTLER)

Dyslipidemia | Hypercholesterolemia

Greece
Elpen Pharmaceutical Co. Inc.

Completed

BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study (BALLOON)

Asthma

Greece
Elpen Pharmaceutical Co. Inc.

Completed

ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE (ADVANCE)

Dementia | Alzheimer Disease | Cognitive Disorders

Greece
22nd Century Group, Inc.
Vince & Associates Clinical Research, Inc.

Completed

Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes

Tobacco Use

United States
Arshad Khanani
Genentech, Inc.

Completed

Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME

Diabetic Macular Edema

United States
Barrie Urology Associates
Astellas Pharma Canada, Inc.

Completed

Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms

Urinary Bladder, Overactive | Flank Pain

Canada
Southeast Clinical Research Associates, LLC
Genentech, Inc.

Completed

Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

Exudative Age Related Macular Degeneration

United States
Retina Vitreous Associates of Florida
Genentech, Inc.

Completed

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

Diabetic Retinopathy | Macular Edema

United States
Northern California Retina Vitreous Associates
Genentech, Inc.

Completed

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. (RESCUE)

Recalcitrant Wet Age-related Macular Degeneration

United States
bioAffinity Technologies Inc.
Radiology Associates of Albuquerque

Completed

Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

Lung Cancer

United States
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt. (TRITON)

COPD
Elpen Pharmaceutical Co. Inc.

Not yet recruiting

TorasEmide Induced Effect on Quality of Life and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. (ESTIA)

Chronic Heart Failure
Elpen Pharmaceutical Co. Inc.

Recruiting

Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice. (ARGO)

Copd | COPD Exacerbation

Greece
Elpen Pharmaceutical Co. Inc.

Recruiting

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease. (CURE)

Autoimmune Diseases | Diffuse Cutaneous Systemic Sclerosis | Scleroderma | Digital Ulcer | Reynold Syndrome

Greece
Elpen Pharmaceutical Co. Inc.

Completed

AdHerencE to Treatment and quAlity of Life in COPD (AHEAD)

Quality of Life | Chronic Obstructive Pulmonary Disease | Compliance, Patient

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®

Asthma

Czechia
Elpen Pharmaceutical Co. Inc.

Completed

Multiple Electrode Aggregometry & Clopidogrel Resistance

Coronary Artery Disease (CAD) | Type 2 Diabetes Mellitus (T2DM) | Myocardial Infraction

Greece
Elpen Pharmaceutical Co. Inc.

Withdrawn

Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation (PRESERVE-SR)

Recurrence | Atrial Fibrillation
Elpen Pharmaceutical Co. Inc.

Completed

PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENT (PLATINUM)

Quality of Life | Dyslipidemias | Hyperlipidemias | Risk Factor, Cardiovascular

Greece
Elpen Pharmaceutical Co. Inc.

Completed

EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece (AEOLOS)

Chronic Obstructive Pulmonary Disease

Greece
Elpen Pharmaceutical Co. Inc.

Completed

COMPLliancE and qualiTy of lifE in Asthma (COMPLETE)

Quality of Life | Asthma | Compliance, Patient

Greece
Elpen Pharmaceutical Co. Inc.

Completed

eVAluatIon of OLanzapine TreatmEnT (VIOLET)

Schizophrenia | Bipolar Disorder

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Osteoporosis Screening Trial (OSTRIA)

Osteoporosis

Greece
Elpen Pharmaceutical Co. Inc.

Completed

A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method. (INSPIRE)

Pulmonary Disease

Greece
Elpen Pharmaceutical Co. Inc.

Completed

Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR). (PAPILOBSGR)

Papillomavirus Infections

Greece

3

Subscribe